Matthew Plunkett

Overview

Matthew Plunkett received an average of $2M in total compensation, including $321K in salary, at Nkarta between 2019 and 2020. Matthew Plunkett also received an average of $1M at CTI BioPharma from 2012 to 2017.

Related executives

We found 18 more executives who work or worked at Nkarta and CTI BioPharma.

Paul Hastings

Nkarta

Chief Executive Officer

Alicia Hager

Nkarta

Chief Legal Officer

Nadir Mahmood

Nkarta

Chief Financial and Business Officer

Kanya Rajangam

Nkarta

Chief Medical Officer

Adam Craig

CTI BioPharma

Chief Executive Officer

Bruce Seeley

CTI BioPharma

Chief Operating Officer

David Kirske

CTI BioPharma

Chief Financial Officer

Jack Singer

CTI BioPharma

Chief Scientific Officer

News

You may also like